Top Companies in Remote Patient Monitoring (RPM) Market

The remote patient monitoring market is projected to reach USD 56.94 billion by 2030 from USD 27.72 billion in 2024, at a high CAGR of 12.7% during the forecast period. The main driver behind this high rate of growth is an increasingly aging population needing more healthcare as well as growing demand for ease of access in health care choices. Telehealth and RPM technologies save money by making healthcare work better and reducing stress on hospitals and medical staff. In addition, it allows patients to receive continuous care from home that can lead to better health as well as improve care delivery. However, differences in regulations across regions could slow down the market’s growth, requiring careful attention to ensure these technologies can be widely adopted.

The remote patient monitoring market is dominated by key players. The major players operating in this market are, Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), VitalConnect (US), VivaLNK, Inc (US), Clear Arch, Inc (US), Optum, Inc (Vivifyhealth) (US), Blue Spark Technologies, Inc (US), Lightbeam (US), Cloud Diagnostics Canada ULC (Canada), Teladoc Health, Inc (US), Guangdong Transtek Medical Electronics Co., Ltd (China), CareSimple Inc (Canada), TimeDoc, Inc (US), MD Revolution Inc (US), Optimize Health, Inc (US), Health Recovery Solutions (US), Current Health (US), and Tenovi (US).

To know about the assumptions considered for the study download the pdf brochure

Koninklijke Philips N.V. (Netherlands)

Koninklijke Philips N.V. (Royal Philips) is the parent company of the Philips Group. The company works in four areas: Personal Health, Diagnosis & Treatment, Connected Care, and Others. The company aims to grow in both natural ways and by buying other businesses to increase its market presence. Strategic partnerships in high-potential markets and collaborations have been Philips’ key growth strategy over the years. For example, in July 2024, Bon Secours Mercy Health (US) announced a 10-year partnership with Philips to implement and scale a new patient monitoring platform across its 49 hospitals and 1,200 care sites. Philips has made partnerships with many big healthcare companies and promising AI start-ups in the healthcare field, located in different places. in April 2024, Philips had collaborated with smartQare (Netherlands) to combine their monitoring systems. This will allow patients to be continuously monitored in and out of the hospital using wearable biosensors. Some of its major subsidiaries are Philips Oral Healthcare, LLC (US), Philips GmbH (Germany), Philips Ultrasound, Inc. (US), and Philips Consumer Lifestyle B.V. (Netherlands). It spans operations across North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.

Medtronic (Ireland)

Medtronic is a global healthcare technology company based in Dublin, Ireland. It is an industry leader. The company helps healthcare systems, doctors, clinicians, and patients in more than 150 countries worldwide. It operates through four main business areas: Cardiovascular, Neuroscience, Medical Surgical, and Diabetes. The Cardiovascular segment focuses on the management of heart rhythms, treatment of heart structures, and addressing issues with blood vessels. Neuroscience has various products for surgeries on the spine and brain, and for treating brain-related problems. The Medical Surgical part offers surgical tools, robots that help with surgery, and tools for looking inside the body. Finally, the Diabetes part provides advanced insulin pumps, systems that check blood sugar levels all the time, and smart insulin pens for managing Type 1 and Type 2 diabetes.

Medtronic works on getting product approvals and making partnerships to improve its product range. In August 2024, Medtronic collaborated with Abbott (US) to enhance Medtronic's diabetes care area by incorporating Abbott's advanced glucose monitoring technology. This will enhance Medtronic's products and help patients manage diabetes better. Also, in January 2025, Medtronic reported that the FDA approved and launched the MyCareLink Smart Monitor, first app-based remote monitoring system in the world for pacemaker patients.

Related Reports:

Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com